Share-based Payment Arrangement, Expense of DermTech, Inc. from 30 Sep 2018 to 31 Mar 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
DermTech, Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 30 Sep 2018 to 31 Mar 2024.
  • DermTech, Inc. Share-based Payment Arrangement, Expense for the quarter ending 31 Mar 2024 was $2,697,000, a 43% decline year-over-year.
  • DermTech, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 31 Mar 2024 was $16,526,000, a 16% decline year-over-year.
  • DermTech, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $18,565,000, a 1.9% decline from 2022.
  • DermTech, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $18,934,000, a 43% increase from 2021.
  • DermTech, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $13,276,000, a 166% increase from 2020.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

DermTech, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $16,526,000 $2,697,000 -$2,039,000 -43% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 $18,565,000 $3,151,000 -$2,116,000 -40% 01 Oct 2023 31 Dec 2023 10-K 29 Feb 2024 2023 FY
Q3 2023 $20,681,000 $3,163,000 -$1,773,000 -36% 01 Jul 2023 30 Sep 2023 10-Q 02 Nov 2023 2023 Q3
Q2 2023 $22,454,000 $7,515,000 +$2,678,000 +55% 01 Apr 2023 30 Jun 2023 10-Q 03 Aug 2023 2023 Q2
Q1 2023 $19,776,000 $4,736,000 +$842,000 +22% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024 2024 Q1
Q4 2022 $18,934,000 $5,267,000 +$1,465,000 +39% 01 Oct 2022 31 Dec 2022 10-K 29 Feb 2024 2023 FY
Q3 2022 $17,469,000 $4,936,000 +$1,200,000 +32% 01 Jul 2022 30 Sep 2022 10-Q 02 Nov 2023 2023 Q3
Q2 2022 $16,269,000 $4,837,000 +$1,299,000 +37% 01 Apr 2022 30 Jun 2022 10-Q 03 Aug 2023 2023 Q2
Q1 2022 $14,970,000 $3,894,000 +$1,694,000 +77% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023 2023 Q1
Q4 2021 $13,276,000 $3,802,000 +$2,302,000 +153% 01 Oct 2021 31 Dec 2021 10-K 02 Mar 2023 2022 FY
Q3 2021 $10,974,000 $3,736,000 +$2,336,000 +167% 01 Jul 2021 30 Sep 2021 10-Q 03 Nov 2022 2022 Q3
Q2 2021 $8,638,000 $3,538,000 +$2,438,000 +222% 01 Apr 2021 30 Jun 2021 10-Q 08 Aug 2022 2022 Q2
Q1 2021 $6,200,000 $2,200,000 +$1,200,000 +120% 01 Jan 2021 31 Mar 2021 10-Q 13 May 2021 2021 Q1
Q4 2020 $5,000,000 $1,500,000 +$1,500,000 01 Oct 2020 31 Dec 2020 10-K 10 Mar 2022 2021 FY
Q3 2020 $3,500,000 $1,400,000 +$700,000 +100% 01 Jul 2020 30 Sep 2020 10-Q 09 Nov 2021 2021 Q3
Q2 2020 $2,800,000 $1,100,000 +$800,000 +267% 01 Apr 2020 30 Jun 2020 10-Q 04 Aug 2021 2021 Q2
Q1 2020 $2,000,000 $1,000,000 +$700,000 +233% 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021 2021 Q1
Q4 2019 $1,300,000 $0 01 Oct 2019 31 Dec 2019 10-K 10 Mar 2022 2021 FY
Q3 2019 $700,000 +$500,000 +250% 01 Jul 2019 30 Sep 2019 10-Q 10 Nov 2020 2020 Q3
Q2 2019 $300,000 01 Apr 2019 30 Jun 2019 10-Q 05 Aug 2020 2020 Q2
Q1 2019 $300,000 01 Jan 2019 31 Mar 2019 10-Q 13 May 2020 2020 Q1
Q3 2018 $200,000 01 Jul 2018 30 Sep 2018 10-Q 07 Nov 2019 2019 Q3

DermTech, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $18,565,000 -$369,000 -1.9% 01 Jan 2023 31 Dec 2023 10-K 29 Feb 2024 2023 FY
2022 $18,934,000 +$5,658,000 +43% 01 Jan 2022 31 Dec 2022 10-K 29 Feb 2024 2023 FY
2021 $13,276,000 +$8,276,000 +166% 01 Jan 2021 31 Dec 2021 10-K 02 Mar 2023 2022 FY
2020 $5,000,000 +$3,700,000 +285% 01 Jan 2020 31 Dec 2020 10-K 10 Mar 2022 2021 FY
2019 $1,300,000 +$400,000 +44% 01 Jan 2019 31 Dec 2019 10-K 10 Mar 2022 2021 FY
2018 $900,000 01 Jan 2018 31 Dec 2018 10-K 11 Mar 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.